Kolinsky Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$624K Sell
7,253
-98
-1% -$10.6K 0.38% 51
2024
Q3
$875K Buy
7,351
+289
+4% +$38.5K 0.57% 31
2024
Q2
$1.01M Buy
7,062
+148
+2% +$19.6K 0.72% 21
2024
Q1
$888K Buy
6,914
+215
+3% +$25.6K 0.68% 25
2023
Q4
$693K Sell
6,699
-43
-0.6% -$4.25K 0.61% 26
2023
Q3
$613K Buy
6,742
+860
+15% +$75.8K 0.61% 29
2023
Q2
$462K Buy
5,882
+10
+0.2% +$817 0.44% 57
2023
Q1
$467K Sell
5,872
-988
-14% -$70.1K 0.5% 44
2022
Q4
$464K Sell
6,860
-434
-6% -$25.4K 0.53% 39
2022
Q3
$363K Buy
7,294
+188
+3% +$10.1K 0.45% 44
2022
Q2
$396K Buy
7,106
+1,496
+27% +$83K 0.47% 45
2022
Q1
$311K Buy
+5,610
New +$288K 0.31% 74

Other funds holding NVO